213 related articles for article (PubMed ID: 19941988)
1. Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.
Da'dara AA; Harn DA
Vaccine; 2010 Feb; 28(5):1310-7. PubMed ID: 19941988
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.
Shollenberger LM; Bui CT; Paterson Y; Nyhoff L; Harn DA
Vaccine; 2013 Nov; 31(48):5651-8. PubMed ID: 24120546
[TBL] [Abstract][Full Text] [Related]
3. Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.
Dzhivhuho GA; Rehrl SA; Ndlovu H; Horsnell WGC; Brombacher F; Williamson AL; Chege GK
PLoS Pathog; 2018 Jul; 14(7):e1007182. PubMed ID: 30048550
[TBL] [Abstract][Full Text] [Related]
4. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.
Da'Dara AA; Lautsch N; Dudek T; Novitsky V; Lee TH; Essex M; Harn DA
Vaccine; 2006 Jun; 24(24):5211-9. PubMed ID: 16675073
[TBL] [Abstract][Full Text] [Related]
5. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
Joseph S; Jones FM; Laidlaw ME; Mohamed G; Mawa PA; Namujju PB; Kizza M; Watera C; Whitworth JA; Dunne DW; Elliott AM
J Infect Dis; 2004 Aug; 190(3):613-8. PubMed ID: 15243939
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
7. Effect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.
Tweyongyere R; Naniima P; Mawa PA; Jones FM; Webb EL; Cose S; Dunne DW; Elliott AM
PLoS Negl Trop Dis; 2013; 7(10):e2501. PubMed ID: 24147175
[TBL] [Abstract][Full Text] [Related]
8. Praziquantel Treatment of
Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
Front Immunol; 2021; 12():748387. PubMed ID: 34956183
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.
Mohammed ES; Nakamura R; Kalenda YD; Deloer S; Moriyasu T; Tanaka M; Fujii Y; Kaneko S; Hirayama K; Ibrahim AI; El-Seify MA; Metwally AM; Hamano S
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008518. PubMed ID: 32915790
[TBL] [Abstract][Full Text] [Related]
11. IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
Wilson MS; Cheever AW; White SD; Thompson RW; Wynn TA
PLoS Pathog; 2011 Aug; 7(8):e1002171. PubMed ID: 21829367
[TBL] [Abstract][Full Text] [Related]
12. Immunization with adult
El-Aswad BEW; Harba NM; Moharm IM; Mahmoud SF
J Helminthol; 2019 Jan; 94():e26. PubMed ID: 30702051
[TBL] [Abstract][Full Text] [Related]
13. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
Brindley PJ; Strand M; Norden AP; Sher A
Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope.
Bui CT; Shollenberger LM; Paterson Y; Harn DA
Clin Vaccine Immunol; 2015 Feb; 22(2):193-9. PubMed ID: 25520148
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
16. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S
APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022
[TBL] [Abstract][Full Text] [Related]
17. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.
McCusker P; Rohr CM; Chan JD
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009200. PubMed ID: 33657133
[TBL] [Abstract][Full Text] [Related]
19. Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.
Alves CC; Araujo N; dos Santos VC; Couto FB; Assis NR; Morais SB; Oliveira SC; Fonseca CT
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003537. PubMed ID: 25723525
[TBL] [Abstract][Full Text] [Related]
20. IMMUNOPROTECTION OF SOLUBLE EGG ANTIGENS AND PRAZIQUANTEL IN CHALLENGED MURINE SCHISTOSOMIASIS MANSONI.
El-Aal NFA; Mohammed FA; Magdy M
J Egypt Soc Parasitol; 2017 Apr; 47(1):1-12. PubMed ID: 30157327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
